Lv3
278 积分 2022-06-16 加入
Tumour lysis syndrome
1个月前
已完结
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
1个月前
已完结
The Tumor Lysis Syndrome
1个月前
已完结
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
1个月前
已完结
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
2个月前
已完结
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
2个月前
已完结
Myelodysplastic syndromes versus acute myeloid leukaemia: biology or blasts—what truly defines the disease and does it matter?
2个月前
已完结
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
The conundrum of drug development in higher-risk MDS: Lessons learned from recently failed phase 3 clinical trials
2个月前
已完结
Myelodysplastic syndromes versus acute myeloid leukaemia: biology or blasts—what truly defines the disease and does it matter?
3个月前
已关闭